SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-041589
Filing Date
2024-10-18
Accepted
2024-10-18 16:56:08
Documents
14
Period of Report
2024-10-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38462
2 ex3-2b.htm EX-3.2B 6975
  Complete submission text file 0001493152-24-041589.txt   223878

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ensc-20241018.xsd EX-101.SCH 3012
4 XBRL LABEL FILE ensc-20241018_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ensc-20241018_pre.xml EX-101.PRE 24163
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3814
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 241381295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)